Antitumor Activity of Benzamide Riboside In Vitro and In Vivo

Title: Antitumor Activity of Benzamide Riboside In Vitro and In Vivo

Volume: 9 Issue: 7

Author(s): Ladislav Novotny, Peter Rauko, Joel A. Yalowitz and Thomas Szekeres

Affiliation:

Keywords: antitumor activity, benzamide riboside, staurosporine, cytarabine, cisplatin, combination therapy, apoptosis

Abstract: Benzamide riboside (BR), a recent synthetic nucleoside analogue, is a new compound demonstrating potent cytotoxic activity in malignant cell lines in vitro and in vivo in L1210 leukemia. It exhibits at least two different mechanisms of action. These are, first, the inhibition of inosine 5-monophosphate dehydrogenase (IMPDH, EC 1.1.1.205), a rate-limiting enzyme for GTP and dGTP synthesis that plays a major role in DNA synthesis, cell proliferation and regulation and second, the induction of apoptosis. Some aspects of BR activity in malignant cells in vitro and in vivo are reviewed as well as some of the mechanisms behind BRs anti-neoplastic effect.

Cite this article as:

Novotny Ladislav, Rauko Peter, Yalowitz A. Joel and Szekeres Thomas, Antitumor Activity of Benzamide Riboside In Vitro and In Vivo, Current Medicinal Chemistry 2002; 9(7) . https://dx.doi.org/10.2174/0929867024606894